Abstract
In this study, the cost of having high blood pressure treated by French general practitioners was estimated, using an analysis of the computerized records for 28,015 patients with either hypertension or history of hypertension over three years. Costs due to visits, drugs, and complementary tests were included. The average annual cost of treatment was 597€ (SD 377€). The annual average cost of drugs was 447€, and antihypertensive drugs 258€. The average annual cost of patients who were controlled throughout the period was 537€, patients who were normalized cost 595€, and patients who deteriorated cost 612€.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agence Nationale d’Accréditation et d’Evaluation en Santé Management of adults with essential hypertension.: Clinical Practice Recommendations and Economic Data. ANAES, Paris (2000)
Alexander, M., Tekawa, I., Hunkeler, E., Fireman, B., Rowell, R., Selby, J. et al.: Evaluating hypertension control in a managed care setting. Arch. Intern. Med 159, 2673–2677 (1999)
Barrie, W.: Cost-effective therapy for hypertension. West. J. Med. 164, 303–309 (1996)
Berlowitz, D.R., Ash, A.S., Hickey, E.C., Friedman, R.H., Glickman, M., Kader, B., Moskowitz, M.A.: Inadequate management of blood pressure in a hypertensive population. N. Engl. J. Med. 339, 1957–1963 (1998)
Burt, V.L., Cutler, J.A., Higgins, M., Horan, M.J., Labarthe, D., Whelton, P. et al.: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examinations Surveys, 1960 to 1991. Hypertension 26, 60–69 (1995)
Cambou, J-P.: Hypertension artérielle essentielle, risque absolu et décision d’intervention chez le malade hypertendu. Rev. Prat. 49, 503–509 (1999)
Chalmers, J., Chusid, P., Cohn, J. et al.: Practice guidelines for primary care physicians. WHO/ISH Hypertension Guidelines. WHO, Geneva (1999)
Day, K., Booyens, S.: The cost-effectiveness of managed care regarding chronic medicine prescriptions in a selected medical scheme. Curationis 21, 65–70 (1998)
Editions du VIDAL.: Dictionnaire VIDAL 2000, 76th edn. Editions du VIDAL, Paris (2000)
Egan, B.M., Lackland, D.T., Williams, B., Gunter, N., Tocharoen, A., Beardon, L.: Health care improvement and cost reduction opportunities in hypertensive medicaid beneficiaries. J. Clin. Hypertens. 3,279–82, 318 (2001)
Fender, P., Païta, M., Salavane, B., Ganay, D., Allemand, H.: Dépenses du Régime général de l’Assurance-Maladie en 1994 pour les trente affections de longue durée. Santé Publique 12, 5–19 (2000)
Frérot, L., Le Fur, P., Le Pape, A., Sermet, C.: L’hypertension artérielle en France : prévalence et prise en charge thérapeutique. Série résultats—Report n° 1999/09. CREDES, Paris (1999)
Hajjar, I., Kotchen, T.A.: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2090, 199–206 (2003)
Mar, J., Pastor, R., Abasolo, R.: Costs analysis of ambulatory blood pressure monitoring in mild hypertension. Gac. Sanit. 13, 384–90 (1999)
Paramore, L.C., Halpern, M.T., Lapuerta, P. et al.: Impact of poorly controlled hypertension on healthcare resource utilization and cost. Am. J. Manag. Care. 7, 389–398 (2001)
Poggi, L., Chamontin, B., Lang, T. et al.: Prévalence, traitement et contrôle de l’hypertension artérielle chez les consultants en médecine générale en France en 1994. Arch. Mal. Cœur. Vaiss. 89, 1075–80 (1996)
Pozuelo, G., Vergeles-Blanca, J.M., Molina, L., Cordero, J.A., Buitrago, F.: Drug savings and the outpatient monitoring of arterial pressure in a group of hypertensive patients. Aten. Primaria. 15, 329–32 (1997)
Schueler K.: Cost-effectiveness issues in hypertension control. Can. J. Public. Health. 85, S54–6 (1994)
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.: Sixth report. Arch. Intern. Med. 157, 2413–2446 (1997)
Union des Caisses Nationales de Sécurité Sociale Nomenclature Générale des Actes Professionnels.: Nomenclature des Actes de Biologie Médicale. UCANSS, Paris (2000)
World Hypertension League. Economics of hypertension control. Bull. World. Health. Organ. 73, 417–24 (1995)
WHO-International society of hypertension guidelines for the management of hypertension. J Hypertens. 17, 151–83 (1999)
Wolf-Maier, K., Cooper, R.S., Banegas, J.R., Giampaoli, S., Hense, H.W., Joffres, M. et al.: Hypertension prevalence and blood pressure in 6 European countries, Canada, and the United States. JAMA 289, 2363–2369 (2003)
Wolf-Maier, K., Cooper, R.S., Kramer, H., Banegas, J.R., Giampaoli, S., Joffres, M. et al.: Hypertension treatment and control in five European countries, Canada and the United States. Hypertension 43, 10–17 (2004)
Acknowledgments
This study was funded by a research grant from Bristol Myers Squibb, France.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tibi-Levy, Y., de Pouvourville, G., Westerloppe, J. et al. The cost of treating high blood pressure in general practice in France. Eur J Health Econ 9, 229–236 (2008). https://doi.org/10.1007/s10198-007-0065-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-007-0065-2